24 related articles for article (PubMed ID: 38448375)
1. [A multicenter study on the accuracy of PAX1/JAM3 dual genes methylation testing for screening cervical cancer].
Shang X; Kong LH; Xiao XP; Wan R; Wang J; Wu HW; Chen XY; Shou HF; Fei J; Zhou JW; Lang JH; Li L
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1852-1859. PubMed ID: 38782754
[No Abstract] [Full Text] [Related]
2. DNA methylation markers in esophageal cancer.
Xu Y; Wang Z; Pei B; Wang J; Xue Y; Zhao G
Front Genet; 2024; 15():1354195. PubMed ID: 38774285
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
Kim MK; Lee IH; Lee KH; Lee YK; So KA; Hong SR; Hwang CS; Kee MK; Rhee JE; Kang C; Hur SY; Park JS; Kim TJ
J Gynecol Oncol; 2016 Mar; 27(2):e14. PubMed ID: 26768780
[TBL] [Abstract][Full Text] [Related]
4. Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management.
Castle PE; Aslam S; Behrens C
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1595-1599. PubMed ID: 27587789
[TBL] [Abstract][Full Text] [Related]
5. Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
Lindroth Y; Pedersen L; Alssamaray J; Berglund T; Sundqvist A; Borgfeldt C; Forslund O
Acta Obstet Gynecol Scand; 2024 Feb; 103(2):378-386. PubMed ID: 37964497
[TBL] [Abstract][Full Text] [Related]
6. PAX1/JAM3 Methylation and HPV Viral Load in Women with Persistent HPV Infection.
Li M; Zhao C; Zhang X; Li J; Zhao Y; Zhang W; Ren L; Wei L
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611108
[TBL] [Abstract][Full Text] [Related]
7. Methylated
Su Y; Tang Y; Zhang T; Xu Y; Zhang Y; Shen Y; Qin L; Zhang L; Cao L; Zhou Y; Liou Y; Zhang M
Future Oncol; 2022 Jul; 18(23):2583-2592. PubMed ID: 35758002
[TBL] [Abstract][Full Text] [Related]
8. High
Li X; He S; Zhao X; Sun D; Wu S; Xu D; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1820-1829. PubMed ID: 38448375
[TBL] [Abstract][Full Text] [Related]
9. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
10. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
12. The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screening.
Fang C; Wang SY; Liou YL; Chen MH; Ouyang W; Duan KM
Mol Genet Genomic Med; 2019 Mar; 7(3):e506. PubMed ID: 30636379
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
